Related references
Note: Only part of the references are listed.Triheteromeric NR1/NR2A/NR2B Receptors Constitute the Major N-Methyl-D-aspartate Receptor Population in Adult Hippocampal Synapses
Claudia Rauner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Memory related dysregulation of hippocampal function in major depressive disorder
Scott L. Fairhall et al.
BIOLOGICAL PSYCHOLOGY (2010)
Impact of cognitive impairment on coping strategies in multiple sclerosis
Benedetta Goretti et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Effects of Electroconvulsive Therapy and Propofol on Spatial Memory and Glutamatergic System in Hippocampus of Depressed Rats
Jun Dong et al.
JOURNAL OF ECT (2010)
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Carlos Zarate et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
Cognitive Deterioration After Venlafaxine Overdose
Ignacio García-Cabeza et al.
JOURNAL OF EMERGENCY MEDICINE (2009)
Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
Denis J. David et al.
NEURON (2009)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Serotonin facilitates long-term depression induction in prefrontal cortex via p38 MAPK/Rab5-mediated enhancement of AMPA receptor internalization
Ping Zhong et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression
J. Douglas Bremner et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain
Ibrahim Eren et al.
NEUROCHEMICAL RESEARCH (2007)
Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat
Ibrahim Eren et al.
NEUROCHEMICAL RESEARCH (2007)
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram
N. Klein et al.
PSYCHOPHARMACOLOGY (2006)
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
V Kepe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression
B Karolewicz et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism
EY Yuen et al.
JOURNAL OF NEUROSCIENCE (2005)
Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and α1-adrenoceptors
K Tachibana et al.
NEUROSCIENCE LETTERS (2004)
Behavioral and cardiovascular changes in the chronic mild stress model of depression
AJ Grippo et al.
PHYSIOLOGY & BEHAVIOR (2003)
Fluvoxamine suppresses the long-term potentiation in the hippocampal CAl field of anesthetized rats:: an effect mediated via 5-HT1A receptors
T Kojima et al.
BRAIN RESEARCH (2003)
Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy
C Wikell et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2002)
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care
A Wade et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Dysfunction in the neural circuitry of emotion regulation - A possible prelude to violence
RJ Davidson et al.
SCIENCE (2000)